Chiron
Executive Summary
President and COO Hollings Renton, 46, resigns, effective July 1. Until then Renton, 46, will concentrate on Chiron alliance with Berlex for Betaseron (recombinant beta interferon), manufacturing expansion and transition of responsibilities. He will remain a member of the board. Renton is the former COO of Cetus, which Chiron acquired in 1991.